Marcus D. Flather
#139,742
Most Influential Person Now
Marcus D. Flather's AcademicInfluence.com Rankings
Marcus D. Flatherphilosophy Degrees
Philosophy
#7248
World Rank
#10435
Historical Rank
Logic
#4306
World Rank
#5580
Historical Rank
Marcus D. Flatherbiology Degrees
Biology
#9831
World Rank
#13081
Historical Rank
Biochemistry
#1516
World Rank
#1645
Historical Rank
Download Badge
Philosophy Biology
Marcus D. Flather's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Biochemistry Stanford University
Similar Degrees You Can Earn
Why Is Marcus D. Flather Influential?
(Suggest an Edit or Addition)Marcus D. Flather's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) (5238)
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (2006) (2183)
- Predictors of hospital mortality in the global registry of acute coronary events. (2003) (2077)
- ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (2001) (1865)
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction (1995) (1755)
- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients (2000) (1551)
- Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). (2005) (1481)
- Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) (2006) (1396)
- A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry (2004) (1084)
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial (2010) (1009)
- ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
- Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. (2007) (903)
- Apixaban with antiplatelet therapy after acute coronary syndrome. (2011) (872)
- Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials (2009) (730)
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017) (713)
- Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction (2018) (698)
- A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. (2004) (677)
- Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). (2002) (675)
- Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease (2015) (640)
- Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. (1998) (632)
- A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. (2004) (630)
- Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. (2007) (625)
- European Society of Cardiology: Cardiovascular Disease Statistics 2017. (2018) (573)
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial (2017) (558)
- European Society of Cardiology: Cardiovascular Disease Statistics 2019. (2019) (529)
- Cardiovascular Efficacy and Safety of Bococizumab in High‐Risk Patients (2017) (488)
- Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. (2010) (486)
- Darapladib for preventing ischemic events in stable coronary heart disease. (2014) (475)
- Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). (2009) (449)
- Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial (2008) (442)
- The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data (1995) (425)
- Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data (2018) (423)
- Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (2014) (399)
- Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events (2008) (389)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
- Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials (2018) (372)
- Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation (1998) (371)
- Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials (2008) (311)
- Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. (2016) (308)
- Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease (2016) (267)
- Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). (2010) (265)
- Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation: Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial (2012) (263)
- From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). (2003) (263)
- Bilateral versus Single Internal‐Thoracic‐Artery Grafts at 10 Years (2019) (259)
- ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. (1995) (255)
- Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data (2002) (246)
- Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. (2008) (239)
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study (2013) (235)
- Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS) (2008) (234)
- Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. (2004) (227)
- The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study (2013) (222)
- Strengths and limitations of meta-analysis: larger studies may be more reliable. (1997) (219)
- Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. (2002) (218)
- Irbesartan in patients with atrial fibrillation. (2011) (215)
- Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK) (2000) (214)
- Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials (1996) (197)
- Reply to comment (2002) (189)
- Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. (2017) (174)
- Prevalence and outcome of subclinical rheumatic heart disease in India: The RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study (2011) (171)
- One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. (2005) (169)
- Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure (2001) (161)
- Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab (2000) (161)
- Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial (2001) (154)
- Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease (2010) (150)
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin–Acute Coronary Syndromes Trial (2011) (147)
- Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. (2006) (144)
- Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial. (2016) (143)
- APPRAISE 2. Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome for the APPRAISE-2 Investigators* (2011) (136)
- Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study. (2014) (134)
- The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP). (2014) (129)
- Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). (2003) (125)
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin–Coronary Artery Disease Trial (2011) (123)
- Pulmonary atresia with intact ventricular septum: predictors of early and medium-term outcome in a population-based study. (2005) (121)
- Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. (1998) (121)
- Predictors of clinical outcomes in elderly patients with heart failure (2011) (116)
- Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265] (2006) (116)
- Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. (2006) (115)
- Randomized Comparison of Stentless Versus Stented Valves for Aortic Stenosis: Effects on Left Ventricular Mass (2005) (113)
- European Society of Cardiology: cardiovascular disease statistics 2021. (2022) (113)
- Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial (2017) (112)
- The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. (2012) (107)
- Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE) (2005) (106)
- Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2. (2005) (97)
- Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial (2009) (96)
- Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis (2016) (95)
- Expert consensus document on management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) (95)
- Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicentre European trial. (1998) (95)
- Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). (2012) (93)
- Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. (2011) (90)
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction: The GEOSTAT-1 Study (2010) (90)
- The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease (2009) (88)
- Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. (2007) (85)
- Heart rate variability in acute myocardial infarction and its association with infarct site and clinical course. (1991) (84)
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina (2001) (83)
- Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. (2018) (83)
- Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials. (2011) (81)
- Preoperative 6-minute walk test adds prognostic information to Euroscore in patients undergoing aortic valve replacement (2009) (81)
- Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain (2019) (79)
- Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. (1995) (79)
- An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. (2007) (77)
- Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study (2011) (77)
- Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. (2007) (77)
- Recent developments in atrial fibrillation (2005) (74)
- Diuretics for heart failure. (2012) (73)
- Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study) (2008) (72)
- Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS (2012) (70)
- Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. (2010) (69)
- Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy (2021) (69)
- Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial (2019) (68)
- Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. (2001) (67)
- Generalizing results of randomized trials to clinical practice: reliability and cautions (2006) (65)
- Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. (2002) (65)
- Magnesium in acute myocardial infarction (1995) (63)
- Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies. (2005) (61)
- The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study) (2004) (61)
- Early Diagnosis of Myocardial Infarction by Timed Sequential Enzyme Measurements (1988) (60)
- Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. (2013) (60)
- Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. (2009) (60)
- Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial (2012) (58)
- Antiplatelet therapy in peripheral arterial disease. Consensus statement. (2003) (58)
- Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial (2017) (57)
- Complete Versus Lesion-Only Primary PCI (2015) (57)
- Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). (2004) (54)
- Five-minute heart rate variability can predict obstructive angiographic coronary disease (2011) (54)
- Diagnosis of elderly patients with heart failure (2012) (54)
- Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease. (2010) (53)
- Valve replacement for aortic stenosis in patients with poor left ventricular function: comparison of early changes with stented and stentless valves. (1999) (52)
- One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial (2004) (50)
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. (2001) (50)
- The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. (2012) (47)
- Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). (2004) (46)
- Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure. (1998) (45)
- Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration (2015) (45)
- The management and investigation of elderly patients with acute coronary syndromes without ST elevation: an evidence-based approach? Results of the Prospective Registry of Acute Ischaemic Syndromes in the United Kingdom (PRAIS-UK). (2005) (44)
- Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. (2006) (44)
- Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial (2017) (42)
- Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. (2002) (41)
- Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial (2017) (41)
- Early and late changes in left ventricular filling after acute myocardial infarction and the effect of infarct size. (1992) (40)
- The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting (2004) (40)
- Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. (2009) (40)
- A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. (2005) (40)
- Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators. (1994) (40)
- Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling. (2005) (39)
- WITHDRAWN: Diuretics for heart failure. (2016) (39)
- High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris (2018) (38)
- Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease (2016) (38)
- Relation of timing of cardiac catheterization to outcomes in patients with non-ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational global registry of acute coronary events. (2005) (38)
- Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial. (2015) (38)
- Treatment for acute myocardial infarction. Overview of randomized clinical trials. (1996) (37)
- Life-style modification in peripheral arterial disease. (2005) (37)
- Effect of total arterial grafting in the Arterial Revascularization Trial. (2020) (36)
- Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST‐Segment Elevation Myocardial Infarction (2017) (35)
- European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary). (2020) (34)
- Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study (2016) (33)
- Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS). (2011) (33)
- Coronary calcification, homocysteine, C‐reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study (2006) (33)
- A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK. (2006) (32)
- β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure (2010) (32)
- Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. (2007) (32)
- Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients (Intervention Review) (2010) (31)
- Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure. (2019) (31)
- Complete and incomplete revascularization in multivessel PTCA: what is the clinical impact? (1998) (31)
- Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design (2013) (30)
- Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery (2020) (30)
- Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). (2005) (29)
- Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. (2021) (29)
- The progress of coronary heart disease in Type 2 diabetes as measured by coronary calcium score from electron beam computed tomography (EBCT): the PREDICT study. (2008) (29)
- A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events – Reduction of Cholesterol to Key European Targets Trial (2009) (27)
- Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study. (1993) (27)
- Evolutionary pattern and prognostic importance of heart rate variability during the early phase of acute myocardial infarction. (2001) (27)
- Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis (2021) (26)
- Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain (2019) (25)
- Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial (2018) (25)
- Large streamlined trials in cardiovascular disease. (2014) (25)
- Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes. (2000) (24)
- Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction (PRAGUE-2 trial). (2003) (24)
- The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. (1999) (24)
- Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study (2017) (24)
- Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure (2012) (23)
- Utility of the SENIORS elderly heart failure risk model applied to the RICA registry of acute heart failure. (2015) (23)
- Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial (2021) (23)
- Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. (2017) (23)
- Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
- The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. (2004) (22)
- Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial (2014) (22)
- Randomized Trials in Cardiac Surgery: JACC Review Topic of the Week. (2020) (21)
- A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol (2013) (21)
- Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1‐year outcomes in the Arterial Revascularization Trial† (2017) (20)
- Potential impact of socioeconomic differences on clinical outcomes in international clinical trials. (2001) (19)
- Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases (2017) (19)
- Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review. (2010) (19)
- Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. (2022) (19)
- Off‐pump versus on‐pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial (2017) (18)
- Advances in antithrombotic drug therapy for coronary artery disease. (1995) (18)
- Ten-year outcomes after off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial. (2020) (18)
- Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction (2018) (18)
- Ischemic mitral regurgitation: in search of the best treatment for a common condition. (2009) (18)
- Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease? (2010) (17)
- Assessing bleeding risk in acute coronary syndromes. (2012) (17)
- Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program (2012) (17)
- The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease (2010) (17)
- Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study (2012) (17)
- The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery. (2011) (17)
- The EURO SHOCK Trial: Design, Aims and Objectives. (2020) (17)
- Cardiovascular disease statistics from the European atlas: inequalities between high- and middle-income member countries of the ESC. (2018) (17)
- Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial. (2012) (16)
- Effects of ACE Inhibitors on Mortality When Started in the Early Phase of Myocardial Infarction: Evidence from the Larger Randomized Controlled Trials (1995) (16)
- Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial. (2021) (16)
- One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial (2017) (15)
- Radial artery pulse wave analysis for non-invasive assessment of coronary artery disease. (2013) (15)
- Incremental Importance of Peak‐Exercise Plasma Levels of Endothelin‐1 and Natriuretic Peptides in Chronic Heart Failure (2001) (15)
- High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel (2015) (15)
- Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosis. (2004) (15)
- B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease (2019) (14)
- High Risk of Peripheral Arterial Disease in the United Kingdom: 2-Year Results of a Prospective Registry (2011) (14)
- Effects of valve replacement on left ventricular function in patients with aortic regurgitation and severe ventricular disease. (2004) (14)
- Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial. (1993) (14)
- Contemporary predictors of coronary artery disease in patients referred for angiography (2010) (14)
- 15 Investigation of IL-1 inhibition in patients presenting with non-ST elevation myocardial infarction acute coronary syndromes (the MRC ILA Heart Study) (2011) (13)
- Rates and causes of death from non-ST elevation acute coronary syndromes: ten year follow-up of the PRAIS-UK registry. (2013) (13)
- Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome (2015) (13)
- Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project protocol and design (2010) (13)
- A trial of early discharge with homecare compared to conventional hospital care for patients undergoing coronary artery bypass grafting (2004) (12)
- Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention. (2017) (12)
- Effects of nebivolol on biomarkers in elderly patients with heart failure. (2014) (12)
- Asymptomatic Carotid Disease and Cardiac Surgery Consensus (2011) (12)
- Can protein biomarkers provide an index of coronary artery calcification in patients with Type 2 diabetes? (2010) (12)
- Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial. (2021) (12)
- Long term prognosis of heart failure after acute coronary syndromes without ST elevation (2006) (11)
- Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study (2016) (11)
- [The Chinese registry on reperfusion strategies and outcomes in ST-elevation myocardial infarction]. (2006) (11)
- Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials (2022) (11)
- Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial) (2018) (10)
- National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. (2003) (10)
- Admission ECG predicts long-term outcome in acute coronary syndromes without ST elevation. (2006) (9)
- Improved recovery after the endoscopic atraumatic coronary artery bypass procedure compared with sternotomy for off-pump bypass of the left internal thoracic artery to the left anterior descending coronary artery: a case-matched study. (2004) (9)
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials (2010) (9)
- Prevalence and predictors of persistent health status impairment in patients referred to a vascular clinic with intermittent claudication. (2011) (9)
- Maximizing benefits of therapies in acute myocardial infarction. (1993) (9)
- The SCOT-HEART Investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet doi:10.1016/S0140-6736(15)60291-4 (2015) (8)
- The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting Appendix 1: Fundamentals of Study Design (2004) (8)
- Prospective evaluation of diabetic ischaemic heart disease by computed tomography: the PREDICT study: (2002) (8)
- Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease (2021) (8)
- Abstract 12057: Mitral Valve Annuloplasty in Addition to Coronary Artery Bypass Grafting in Moderate Functional Ischemic Mitral Regurgitation Reverses Left Ventricular Remodelling and Restores Left Ventricular Geometry: Preliminary Results of the Randomised Ischemic Mitral Evaluation Trial (2011) (8)
- European Society of Cardiology: cardiovascular disease statistics 2021. (2022) (8)
- HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION (1992) (7)
- Isis-4 pilot study: Serial hemodynamic changes with oral captopril and oral isosorbide mononitrate in a randomized double-bund trial in acute myocardial infarction (1991) (7)
- A description of the characteristics of patients with non-ST elevation acute coronary syndromes admitted to different settings in the 1990s. (2008) (6)
- Managing high-risk patients with acute coronary syndromes: the Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). (2004) (6)
- Septal q waves as an indicator of risk of mortality in elderly patients with chronic heart failure. (2002) (6)
- Comparison of drug-eluting and bare-metal stents in patients with diabetes undergoing primary percutaneous coronary intervention: what is the evidence? (2014) (6)
- Ischemia and Infarction in STEMI Patients With Multivessel Disease: Insights From the CvLPRIT Nuclear Substudy. (2016) (6)
- Effect of Bruton's tyrosine kinase inhibitors on platelet aggregation in patients with acute myocardial infarction. (2019) (6)
- Incremental cost-effectiveness of early and long-term clopidogrel in patients undergoing percutaneous coronary infarction in the CURE trial: The PCI-CURE economic analysis (2003) (6)
- Randomised trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. WHISP (Women's Hormone Intervention Secondary Prevention Study) Pilot Study Investigators (2006) (5)
- Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study (2019) (5)
- A 6-Point TACS Score Predicts In-Hospital Mortality Following Total Anterior Circulation Stroke (2016) (5)
- Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting. (2022) (5)
- GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction? (1990) (5)
- Retraction: Shamim et Al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326-33. (2003) (5)
- Assessment of data quality in an international multi-centre randomised trial of coronary artery surgery (2011) (5)
- Disagreement Between Randomized and Observational Evidence on the Use of Bilateral Internal Thoracic Artery Grafting: A Meta‐Analytic Approach (2019) (5)
- Coronary heart disease in women. (2000) (5)
- First line treatment with colchicine reduced recurrent pericarditis (2006) (5)
- New horizons in management of heart failure in older patients. (2019) (4)
- Determinants of Length of Stay Following Total Anterior Circulatory Stroke (2017) (4)
- Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial (2018) (4)
- Influence of baseline ejection fraction on effects of nebivolol (Beta-1 blocker) in elderly patients with heart failure (2006) (4)
- Recent advances and future directions in myocardial infarction. (1994) (4)
- The stent or surgery trial longer term follow up (2006) (4)
- THE COMPLETE VERSUS LESION ONLY PRIMARY PCI TRIAL-CARDIOVASCULAR MRI SUBSTUDY (CVLPRIT-CMR) (2015) (4)
- Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials (2022) (4)
- 1040-71 Interhospital transfers are costly, cause delays and do not address the imbalance of access to revascularization: The case for more angiographic facilities? Results from the global registry of acute coronary events (2004) (4)
- THE ROLE OF TIROFIBAN IN ACUTE CORONARY SYNDROMES (2000) (3)
- Association between sternal wound complications and 10-year mortality following coronary artery bypass grafting. (2021) (3)
- 404 Effects of Nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) (2005) (3)
- Prevalence of Anaemia and the Effects of Nebivolol on Haemoglobin Values in Patients with Chronic Heart Failure: Results from the SENIORS Database (2009) (3)
- Understanding Mechanisms of Action of Beta-Blockers in Heart Failure With Reduced and Preserved Ejection Fraction. (2016) (3)
- Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis (2017) (3)
- β blockers in patients with heart failure and atrial fibrillation – Authors' reply (2015) (3)
- Tolerability and dose-related effects of nebivolol in elderly patients with heart failure : data from the SENIORS trial (2007) (3)
- What Goes Into a Major Acute Coronary Syndrome Trial and What Will Future Trials Look Like? (2010) (3)
- 61 Five-min heart rate variability can predict obstructive angiographic coronary disease (2011) (3)
- Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry. (2017) (3)
- Monday, 27 August 2012 (2012) (3)
- Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic Perspective (2010) (2)
- The Scottish computed tomography of the heart ( SCOT-HEART ) trial : study protocol for randomized controlled trial (2013) (2)
- Prognostic factors of 10-year mortality after coronary artery bypass graft surgery: a secondary analysis of the arterial revascularization trial. (2022) (2)
- 19 The randomised complete vs. lesion only primary PCI trial – cardiovascular MRI substudy (CVLPRIT-CMR) (2015) (2)
- A short course of l-arginine improves exercise capacity and endothelial function in chronic heart failure: A prospective, randomised, double blind trial (2001) (2)
- Comparison of bare metal stents versus drug-eluting stents in patients with multivessel disease and diabetes: results from a CARDia Trial substudy (2009) (2)
- Validation of aortic valve pressure gradient quantification using semi-automated 4D flow CMR pipeline (2022) (2)
- Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial. (2022) (2)
- Response to Letter from R. Rosoky and N. Walosker regarding “Life-style Modification in Peripheral Arterial Disease” (2005) (2)
- Kat-ARC accelerated 4D flow CMR: clinical validation for transvalvular flow and peak velocity assessment (2022) (2)
- ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis. (2023) (2)
- Is 5-min Heart Rate Variability Superior to ECG for Identifying Patients with Coronary Artery Disease? (2009) (1)
- The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR) (2016) (1)
- Diuretics for heart failure. (2006) (1)
- First line treatment with colchicine reduced recurrent pericarditis. (2006) (1)
- Women responded to an early invasive strategy as well as men in the acute coronary syndrome. (2003) (1)
- Open access data sharing from clinical trials: is it really feasible? (2015) (1)
- Valvular Heart Disease Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation (2012) (1)
- Improving the management of non-ST elevation acute coronary syndromes : systematic evaluation of a quality improvement programme E uropean (2010) (1)
- Abstract 5881: The in vitro Effects of E5555, a PAR-1 Antagonist, on Platelet Biomarkers in Healthy Volunteers and Patients With Coronary Artery Disease (2009) (1)
- Prevention of cardiovascular disease in women: evidence for the use of hormone replacement therapy (2001) (1)
- Cardiovascular Clinical Trials: Putting the Evidence into Practice (2012) (1)
- Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial (2020) (1)
- Health economic burden of non-ST-segment elevation acute coronary syndromes in Europe. Results from PRAIS-UK (2001) (1)
- Corrigendum to “Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?” [Pharmacol. Ther. 127(2) (2010) 95–107] (2010) (1)
- Reply: Complete Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI: Is It Really What We Should Be Doing? (2015) (1)
- Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years (2021) (1)
- Acute chest pain—are outcomes influenced by the pattern of care—city versus county hospitals? (2002) (1)
- W09.216 Coronary calcification score and conventional cardiovascular risk factors in asymptomatic type 2 diabetic subjects: The predict study (2004) (1)
- PROSPECTIVE EVALUATION OF CORONARY ARTERY CALCIUM IN PREDICTING CARDIOVASCULAR EVENTS IN ASYMPTOMATIC PATIENTS WITH TYPE 2 DIABETES: THE PREDICT STUDY (2008) (1)
- Improved prediction of coronary disease in unselected patients: a ’real-world’ view of pulse wave analysis (2008) (1)
- Angiography and revascularization after thrombolysis: where are we? (2001) (1)
- Validation of time-resolved, automated peak trans-mitral velocity tracking: Two center four-dimensional flow cardiovascular magnetic resonance study. (2022) (1)
- Tuesday, 28 August 2012 (2012) (1)
- Coronary angiography and revascularization for acute coronary syndromes without ST elevation: the next challenge. (2002) (1)
- Abstract 2337: Role of Preoperative 6 Minute Walk Test in the Assessment and Prognosis of Patients with Severe Aortic Stenosis Undergoing Aortic Valve Replacement (2006) (1)
- Abstract 10987: Mitral Valve Annular, Leaflet and Papillary Muscle Geometry and Function in Functional Ischemic Mitral Regurgitation: New Insights from Cardiovascular Magnetic Resonance (2011) (1)
- Bilateral versus Single Internal-Thoracic-Artery Grafts. (2017) (1)
- Sex‐related differences in outcomes after coronary artery bypass surgery—A patient‐level pooled analysis of randomized controlled trials: rationale and study protocol (2020) (1)
- Statistical versus clinical significance of the CURE study in acute coronary syndromes. (2003) (1)
- 63A Utilizing sequential monitoring boundaries for cumulative meta-analysis (1995) (1)
- P66 Is central adjudication necessary to avoid bias in clinical outcomes (1997) (1)
- Cardiovascular examination using hand-held cardiac ultrasound (2021) (1)
- European Heart Journal - Quality of Care and Clinical Outcomes: a new journal for the 21st century. (2015) (1)
- P9 Accuracy and precision of measurements of heparin concentrations by heparin management system during cardiac surgery (1999) (1)
- Randomized Comparison of Single Versus Bilateral Internal Mammary Artery Grafting in 3102 Patients: Effects on Major Cardiovascular Outcomes After Five Years Follow Up (2016) (1)
- Improved Risk Prediction Using Non-Invasive Methods—The Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study (2008) (1)
- Ischemic Mitral Evaluation ( RIME ) Trial Moderate Functional Ischemic Mitral Regurgitation : Final Results of the Randomized Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in (2012) (1)
- Mitral regurgitation quantified by CMR 4D-flow is associated with microvascular obstruction post reperfused ST-segment elevation myocardial infarction (2022) (1)
- With Atrial Fibrillation (RELY-ABLE) Study The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients (2013) (1)
- Resource use and outcomes of high risk patients with acute coronary syndromes awaiting in-hospital transfer. Results from PRAIS-UK (2001) (1)
- Explorer Symptoms and Quality of Life in Patients with Suspected Angina Undergoing Coronary Computed Tomography Angiography (2017) (1)
- Five-year costs from a randomised comparison of bilateral and single internal thoracic artery grafts (2019) (1)
- Pedicled and skeletonized single and bilateral internal mammary artery grafts 3 and the incidence of sternal wound complications : Insights from the Arterial 4 Revascularization (2017) (0)
- Cluster Randomised Trials (2006) (0)
- Results of serial enzyme measurements in acute myocardial infarction support early reperfusion as the goal of therapy. (1996) (0)
- 8 The effect of BTK inhibitors on platelet aggregation in acute coronary syndromes (2018) (0)
- 5 Exaggerated elastin turnover in childhood and adolescence in marfan syndrome - correlation with age - new insights from the aims trial (2021) (0)
- Pitfalls in clinical trial design and methodology (1999) (0)
- Adjunctive therapy for myocardial infarction. (1995) (0)
- Observational Versus Randomized: Sliding Toward Nonevidence-Based Medicine. (2017) (0)
- Edinburgh Research Explorer Symptoms and Quality of Life in Patients with Suspected Angina Undergoing Coronary Computed Tomography Angiography (2018) (0)
- Smoking and antiplatelet therapy after acute coronary syndromes. (2020) (0)
- Post-operative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery (2020) (0)
- Erythropoiesis-Stimulating Agents Improve Left-Ventricular Function and Exercise Tolerance in Anaemic Heart Failure Patients (2009) (0)
- Clinical outcomes and patient satisfaction in the Optimal Surgical Care for Arterial Revascularisation (OSCAR) study (2001) (0)
- 7 Serial measurement of NT-PROBNP AND HS-CRP after acute coronary syndromes could identify patients with higher residual risk (2018) (0)
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. (2015) (0)
- P1779Differential cytokine expression between the coronary and peripheral circulation in patients with ruptured and intact fibrous caps presenting with ST segment myocardial infarction (2017) (0)
- Introduction to r andomized c linical t rials in c ardiovascular d isease (2013) (0)
- THE RELATIONSHIP BETWEEN TOOTH LOSS, CARDIOVASCULAR BIOMARKERS AND OUTCOMES IN PATIENTS WITH STABLE CORONARY HEART DISEASE (2016) (0)
- 5 Plaque erosion pilot study (2017) (0)
- Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization (2019) (0)
- P3612Potential for Bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes (2018) (0)
- The Effect of Internal Mammary Artery Grafts on Long-Term Clinical Outcomes After Coronary Bypass Surgery (2011) (0)
- 122 Influence of diabetes and obesity on mortality and sternal wound complications after coronary artery bypass graft surgery: ten-year follow-up from the arterial revascularisation trial (2020) (0)
- Is Liraglutide Associated With Myocardial Protection in ST-Elevation Myocardial Infarction? (2016) (0)
- Mitral regurgitation quantified by CMR 4D-flow is associated with microvascular obstruction post reperfused ST-segment elevation myocardial infarction (2022) (0)
- Publishing Results of Clinical Trials and Reviewing Papers for Publication (2012) (0)
- Authors’ reply to Cunningham and Messerli and colleagues (2016) (0)
- Design and rational collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome , based on individual patient data : A report from the Marfan Treatment Trialists ' Collaboration (2015) (0)
- WO8-OR-3 PREDICTORS OF PROGRESSION OF CORONARY ARTERY CALCIUM IN TYPE 2 DIABETES: THE PREDICT STUDY (2007) (0)
- Influence of guidelines and results from major clinical trials on medical practice: Findings from the global registry of acute coronary events (GRACE) (2003) (0)
- Effects of diabetes and obesity in patients undergoing coronary artery bypass graft surgery: ten-year results from the Arterial Revascularisation Trial (2020) (0)
- Outcomes after coronary artery bypass graft surgery: systematic review and meta-analysis comparing bilateral versus single internal thoracic artery grafts (2020) (0)
- TCT CONNECT-246 Drug Coated Balloon (DCB)-Only Angioplasty in De Novo Large Vessel vs. Small Vessel Coronary Disease (2020) (0)
- CABG added no benefit to medical therapy for preventing death in coronary artery disease with heart failure (2011) (0)
- Validation of aortic valve pressure gradient quantification using semi-automated 4D flow CMR pipeline (2022) (0)
- Acute Coronary Syndromes (ST Elevation and Non‐ST Elevation) (2012) (0)
- Review policy for supplements (2004) (0)
- P2950 Coronary calcification and cardiovascular risk factors in type 2 diabetes: the prospective evaluation of diabetic ischaemia by coronary tomography (PREDICT) study (2003) (0)
- Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies. (1995) (0)
- Recurrent events in meta-analysis of multiple clinical trials. (1999) (0)
- Clinical outcome definitions (2016) (0)
- 1061-85 Trends in the use of effective cardiac medications in patients with acute myocardial infarction: The GRACE experience (2004) (0)
- Peripheral arterial waveforms for the prediction of death and MI: carotid versus radial pulse wave analysis (2013) (0)
- ATOPAXAR AND ITS EFFECTS ON MARKERS OF PLATELET ACTIVATION AND INFLAMMATION: RESULTS FROM THE LANCELOT PROGRAM (2012) (0)
- University of Birmingham Impact of renal impairment on beta-blocker efficacy in patients with heart failure (2020) (0)
- Determinants of successful endoscopic internal thoracic artery harvesting: a prospective analysis. (2004) (0)
- Sex-associations and CT-coronary angiography-guided management in patients with stable chest pain (2019) (0)
- 146 B-type natriuretic peptide and coronary atherosclerosis: an association dependent on central pulse pressure (2012) (0)
- Keep up with Critical Fields (2012) (0)
- Reply: An Incomplete Story. (2018) (0)
- Alternative Risk Markers in Coronary Artery Disease (ARMCAD Study): Interim Analysis (2007) (0)
- Abstract 14086: Investigation of Inflammatory Markers and Cardiac Events Following Discontinuation of Interleukin-1 Receptor Antagonist in NSTE-ACS Patients (2015) (0)
- Cardiac magnetic imaging scans database lock (2016) (0)
- 16 Validation of time-resolved, automated peak transvalvular velocity tracking through the mitral valve using four-dimensional flow cardiovascular magnetic resonance (2021) (0)
- PCV27 ECONOMIC EVALUATION OF NEBIVOLOL COMPARED WITH PLACEBO IN ELDERLY PATIENTS WITH HEART FAILURE -A MODEL BASED ANALYSIS ALONGSIDE THE SENIORS TRIAL (2007) (0)
- Reducing cardiovascular disease by taking a "polypill" hope or hype? (2014) (0)
- Effects of oral L-arginine supplement on peripheral vascular function in chronic heart failure a prospective, randomised, double-blind, placebo-controlled study (2001) (0)
- Predictive value of segmental extent of late gadolinium enhancement and peak circumferential systolic strain in predicting improvement and normalisation of dysfunctional segments post STEMI (2015) (0)
- Relation of Physical Activity and Cardiorespiratory Fitness with Myocardial Infarction (1994) (0)
- Abstract 3081: CHARISMA (long-term dual anti-platelet therapy): The Impact of Risk Status, Prior History, and Proximity to Recent Cardiovascular Events (2006) (0)
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevationacutecoronarysyndromes:theMRC-ILA (2014) (0)
- Elderly patients are often denied evidence based medical therapies - will guidelines address this? Results from PRAIS-UK (2001) (0)
- Ischaemia and infarction in STEMI patients with multivessel disease. Insights from the Complete versus Lesion-only PRimary PCI Trial (CvLPRIT) Nuclear Substudy (2016) (0)
- 71 Long-term Outcomes of Coarctation of Aorta in East of England – The Norfolk and Norwich and Papworth Hospital Experience (2016) (0)
- Prevention of Cardiovascular Disease in Women: Evidence for the Use of Hormone Replacement Therapy (2001) (0)
- Interpreting clinical trials in acute coronary syndromes : proceedings of an international conference held in Madrid, Spain, 30 January, 1999 (1999) (0)
- Dalteparin in addition to aspirin reduces the early risk of death and new MI among patients with unstable coronary artery disease. (1997) (0)
- Mitral regurgitation quantification by cardiac magnetic resonance imaging (MRI) remains reproducible between software solutions (2021) (0)
- 126 Predictors of Final Left Ventricular Ejection Fraction <35% and Medium-Term Clinical Outcomes in Patients with Multivessel Disease at Stemi (2015) (0)
- Factors influencing the progression of coronary artery calcium deposition in Type 2 diabetes: The PREDICT study (2007) (0)
- Defining risk factor profile of patients with and without coronary artery disease, in a population group in a European country with high burden of heart disease: a case control study from Romania (2006) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Systematic Review of Hirudin in Acute Coronary Syndromes and Percutaneous Coronary Intervention. (2001) (0)
- How safe are hospital at home programmes for CABG? Results of a randomised study (OSCAR) (2001) (0)
- Abstract 20861: B-type Natriuretic Peptide and C-Reactive Protein as Markers of Coronary Atherosclerosis (2010) (0)
- Thienopyridines in Stable Coronary Disease (2010) (0)
- Coronary heart disease (CHD) in patients with intermittent claudication (2004) (0)
- Randomised Controlled Trials: What the Surgeon Needs to Know (2010) (0)
- Contents, Vol. 84, 1994 (1994) (0)
- The Stent or Surgery long-term follow-up (2007) (0)
- the ART (Arterial Revascularization Trial) Investigators (2017). Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial. European Journal of Cardio-Thoracic (3), (2018) (0)
- Eythropoietin for anaemia in heart failure (2009) (0)
- Inter-relationship of endothelin-1 and natriuretic peptide secretory responses to acute exercise in patient with chronic heart failure and healthy controls (2002) (0)
- Estimating the cost-effectiveness of tirofiban for acute coronary syndrome patients managed in a relatively low interventional setting: The United Kingdom (2003) (0)
- 34 Comparison of PCI vs CABG in insulin treated and non-insulin treated diabetic patients in the cardia trial (2011) (0)
- Implications of statin use on the health burden and economic costs of acute coronary syndromes without ST elevation Prospective registry of acute ischaemic syndromes in the United Kingdom (2000) (0)
- The dangers of stopping clopidogrel perioperatively: a cardiologist's perspective (2009) (0)
- Eythropoietin for anaemia in heart failure : a meta-analysis of exercise tolerance, symptoms and clinical outcome improvement (2009) (0)
- ACP Journal Club. CABG added no benefit to medical therapy for preventing death in CAD with heart failure. (2011) (0)
- Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial (2022) (0)
- 135 CLINICAL APPLICATION AND REPRODUCIBILITY OF CENTRAL PRESSURE AUGMENTATION USING RADIAL ARTERY PULSE WAVE ANALYSIS (2013) (0)
- Introduction to Randomized Clinical Trials in Cardiovascular Disease (2012) (0)
- Coronary Heart Disease Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes (2011) (0)
- Data and Safety Monitoring Board interim report (2016) (0)
- Are beta blockers effective in elderly patients wiih heart failure and preserved ejection fraction? Results from the randomised, multinational seniors trial (2006) (0)
- 420 ACE-inhibition for myocardial ischaemia /New aspects of nitrate therapy in ischaemic heart disease (2005) (0)
- Impact of Availability of Catheterization Facilities on Clinical Outcomes in Acute Coronary Syndromes. The Global Registry of Acute Coronary Events (2007) (0)
- Prevalence of Anaemia and the Effects of Nebivolol on Hemoglobin Values in Patients with Chronic Heart Failure (2009) (0)
- Comment on "Hospital admission following a diagnosis of heart failure: is time to first admission telling us what we want to know?" - Reply to comment (2002) (0)
- Influence of age and ejection fraction on the effects of nebivolol in elderly patients with heart failure (2005) (0)
- Resource use and outcomes of acute coronary syndromes stratified by electrocardiogram on admission. Results from PRAIS-UK (2001) (0)
- University of Groningen Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure Beta-Blockers Heart Failure (0)
- Angioplasty now matches surgery in the treatment of multivessel diabetes. Results of 5 year follow up from the BART study (2007) (0)
- Automated 4D flow cardiac MRI pipeline to derive peak mitral inflow diastolic velocities using short-axis cine stack: two centre validation study against echocardiographic pulse-wave doppler (2023) (0)
- SOCIO ECONOMIC, LIFESTYLE AND ANTHROPOMETRIC RISK FACTORS INCREASE ODDS OF DEVELOPING HYPERTENSION MAIN CULPRIT BEHIND CORONARY ARTERY DISEASE IN A DEVELOPING EASTERN EUROPEAN ECONOMY: PP.1.35 (2011) (0)
- 123 Systematic review and meta-analysis comparing bilateral versus single internal thoracic artery grafts in patients with diabetes and obesity undergoing coronary artery bypass graft surgery (2020) (0)
- in Seniors With Heart Failure) (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization and Preserved Left Ventricular Ejection Fraction: Data From SENIORS Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired (2011) (0)
- Abstract 14288: Differential Cytokine Expression in Plaque Erosion and Rupture in ST Segment Elevation Myocardial Infarction (2016) (0)
- T04-P-033 Investigating risk factors for coronary artery disease in an Eastern European economy with a rising burden of cardiovascular diseases (2005) (0)
- Subject Index, Vol. 84, 1994 (1994) (0)
- Pedicled and skeletonized single and bilateral internal mammary artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial (ART). (2019) (0)
- Mechanisms of improved five-year outcomes after coronary CT angiography in patients with stable chest pain (2019) (0)
- In fl ammatory Differences in Plaque Erosion and Rupture in Patients With ST-Segment Elevation Myocardial Infarction (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marcus D. Flather?
Marcus D. Flather is affiliated with the following schools:
